Edit

Parthenon

https://www.parthenontx.com/
Last activity: 12.10.2022
Probably Closed
Categories: Platform
Parthenon Therapeutics is reprogramming the tumor microenvironment to beat cancers.
Mentions
9
Location: United States, Massachusetts, Cambridge
Total raised: $65M

Investors 4

Funding Rounds 1

DateSeriesAmountInvestors
06.11.2021Series A$65M-

Mentions in press and media 9

DateTitleDescription
12.10.2022Parthenon Therapeutics Co-Founder and COO, Olga Granaturova, Recognized as One of the Most fascinating Women in Entrepreneurship by Inc. MagazineOlga Granaturova, Chief Operating Officer, Parthenon Therapeutics Parthenon has achieved impressive results since its founding in 2019. We’ve built a pipeline of first-in-class therapeutics & a platform designed to generate a sustained ...
10.12.2021StartUPDATES: New developments for healthcare startupsHealthmine recently shared an article written by AIS Health with support from EVP of Consulting & Professional Services, Melissa Smith. The article discusses paused measures that may have inflated 2022 Star Ratings, but also offers impo...
06.11.2021Parthenon Therapeutics Raises $65M in Series A CAMBRIDGE, MA, Parthenon Therapeutics announced a $65 million Series A financing led by Northpond Ventures, Pfizer Ventures, and Taiho Ventures. >> Click here for more funding data on Parthenon Therapeutics >> To export Part...
04.11.2021Google Cloud goes deep into financial services with $1 billion CME dealThis is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. I didn’t see this coming. Paid Content 4 ways CEOs can build a successful cloud strategy From PwC...
04.11.2021Google Cloud goes deep into financial services with $1 billion CME dealThis is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. I didn’t see this coming. Paid Content Why empathic leadership is critical to business success Fr...
03.11.2021Pfizer adds to Parthenon's $65M war chest to back battle at the tumor barrierPfizer Ventures is one of many investors ponying up $65 million for a new biotech developing anti-cancer therapies to forge an attack on the protective barrier that shields tumors from the immune system. Parthenon Therapeutics launched Wedn...
03.11.2021Parthenon Therapeutics Raises $65 Million in Series A Funding to Advance Oncology Programs Aimed at Reprogramming the Tumor MicroenvironmentParthenon Therapeutics, a biotech company inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment, today announced a $65 million Series A financing led by Northpond Ventures, Pfizer Ventures, and Taiho Ven...
03.11.2021Pfizer adds to Parthenon's $65M war chest to back battle at the tumor barrierPfizer Ventures is one of many investors ponying up $65 million for a new biotech developing anti-cancer therapies to forge an attack on the protective barrier that shields tumors from the immune system. This is "a novel approach, we b...
-StartUPDATES: New developments for healthcare startupsHealthmine recently shared an article written by AIS Health with support from EVP of Consulting & Professional Services, Melissa Smith. The article discusses paused measures that may have inflated 2022 Star Ratings, but also offers impo...

Reviews 0

Sign up to leave a review

Sign up Log In